Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-25 Purchase | 2024-06-26 4:31 pm | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 277,895 | $2.97 | $825,348 | 6,950,239 (Indirect) | View |
| 2024-06-20 Purchase | 2024-06-25 5:45 pm | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 500,000 | $2.9848 | $1,492,385 | 6,672,344 (Indirect) | View |
| 2024-01-29 Purchase(A) | 2024-04-09 7:08 pm | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 400,000 | $19 | $7,600,000 | 4,958,810 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 4:17 pm | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 400,000 | $19 | $7,600,000 | 4,958,812 (Indirect Direct) | View |
| 2023-11-09 Purchase | 2023-11-14 5:33 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 375,000 | $12.5 | $4,687,500 | 7,083,288 (Indirect) | View |
| 2021-09-17 Purchase | 2021-09-21 5:12 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 1,542,553 | $9.4 | $14,499,998 | 4,708,288 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-04 Conversion | 2024-09-05 4:15 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 19,194,242 | $0 | 17,898,301 (Indirect) | View |
| 2024-09-03 Option Award | 2024-09-05 4:15 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 836,099 | $0 | 17,898,301 (Indirect) | View |
| 2024-05-18 Equity Swap | 2024-05-20 8:08 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Director 10% Owner | 8,317,924 | $0 | 0 (Indirect) | View |
| 2024-05-20 Disposition | 2024-05-20 8:08 pm | N/A 2029-01-17 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Director 10% Owner | 60,450 | $0 | 0 (Direct) | View |
| 2024-04-09 Option Award | 2024-04-11 9:01 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 6,172,344 | $0 | 4,183,002 (Indirect) | View |
| 2024-01-29 Conversion | 2024-01-31 4:17 pm | N/A N/A | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 38,223,094 | $0 | 4,958,812 (Direct) | View |
Ownership | 2024-01-24 8:26 pm | N/A N/A | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 4,558,810 (Direct) | View |
| 2024-01-18 Exercise | 2024-01-22 5:48 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 1,234,636 | $12.74 | 8,317,924 (Indirect) | View |
| 2024-01-18 Exercise | 2024-01-22 5:48 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 1,234,636 | $0 | 8,317,924 (Indirect) | View |
| 2024-01-02 Option Award | 2024-01-04 7:03 pm | N/A 2034-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:55 pm | N/A 2033-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-09-23 Option Award | 2022-09-27 4:51 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 2,000,000 | $7.35 | 1,360,544 (Indirect) | View |
| 2022-01-03 Option Award | 2022-01-04 5:17 pm | N/A 2032-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-09-28 Conversion | 2021-09-30 5:43 pm | N/A N/A | Cue Health Inc. | HLTH | Cui Xiangmin Director | 8,192,468 | $0 | 788,441 (Indirect) | View |
| 2021-09-28 Option Award | 2021-09-30 5:43 pm | N/A N/A | Cue Health Inc. | HLTH | Cui Xiangmin Director | 788,441 | $12.8 | 788,441 (Indirect) | View |
Ownership | 2021-09-23 9:06 pm | N/A N/A | Cue Health Inc. | HLTH | Cui Xiangmin Director 10% Owner | 0 | $0 | 8,192,468 (Indirect) | View |
Ownership | 2021-09-23 9:06 pm | N/A N/A | Cue Health Inc. | HLTH | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 8,192,468 (Direct) | View |
Ownership | 2021-02-16 5:22 pm | N/A N/A | Equillium Inc. | EQ | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 4,271,423 (Indirect) | View |
| 2021-01-04 Option Award | 2021-01-05 7:06 pm | N/A 2031-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 7,650 | $0 | 7,650 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 8:01 pm | N/A 2030-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 7,650 | $0 | 7,650 (Direct) | View |